Self-screening approved by FDA for cervical cancer
Newswise May 25, 2024
A way to self-collect a sample to prevent cervical cancer is now available for women.
The test to self-screen for human papillomavirus (HPV) was approved by the U.S. Food and Drug Administration.
Normally, HPV tests are performed by gynecologists by swabbing the cervix to collect a sample of cells. Now, patients will be able to perform these tests themselves by inserting the swab that will then be sent to a lab for testing.
These self-screenings must be done in a private room inside a doctor’s office, mobile clinic or another health care setting.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries